Kamada Ltd (KMDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KMDA | AMGN | GILD | VRTX | REGN |
| Company | Kamada Ltd | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.36 | 337.03 | 84.39 | 477.70 | 1,149.66 |
| High | 5.44 | 338.70 | 84.65 | 482.04 | 1,165.85 |
| Low | 5.34 | 334.61 | 83.57 | 476.27 | 1,148.13 |
| Last | 5.44 | 337.14 | 84.62 | 481.60 | 1,159.12 |
| Change | +0.17 | +4.22 | +0.73 | +7.44 | +20.31 |
| % Change | +3.13% | +1.27% | +0.87% | +1.57% | +1.78% |
| Volume | 15,195 | 589,502 | 3,313,312 | 355,202 | 299,001 |
| 20-Day Average Volume | 30,050 | 1,707,250 | 6,413,796 | 956,834 | 405,078 |
| Previous Close | 5.27 | 332.92 | 83.89 | 474.16 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.49 | 329.62 | 80.10 | 480.01 | 1,165.82 |
| 20-Day Raw Stochastic | 33.33% | 88.15% | 94.81% | 50.63% | 43.92% |
| 20-Day Relative Strength | 48.57% | 58.17% | 72.81% | 50.80% | 54.19% |
| Weighted Alpha | +0.98 | +27.45 | +19.20 | +34.63 | +42.16 |
| Today's Opinion | 56% Sell | 96% Buy | 88% Buy | 56% Buy | 80% Buy |
| Previous Opinion | 48% Sell | 88% Buy | 88% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 40% Buy | 88% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/12/24 | +1.99% since 09/12/24 | +1.49% since 09/12/24 | +0.43% since 09/12/24 | -0.70% since 09/12/24 |
| Low | 5.26 on 09/17/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 1,134.59 on 09/17/24 |
| High | 5.51 on 09/13/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -4.32% since 08/19/24 | +2.64% since 08/19/24 | +13.36% since 08/19/24 | -1.50% since 08/19/24 | -3.39% since 08/19/24 |
| Low | 5.24 on 09/09/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 |
| High | 5.80 on 08/29/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +7.31% since 06/18/24 | +10.01% since 06/18/24 | +33.64% since 06/18/24 | +2.88% since 06/18/24 | +11.27% since 06/18/24 |
| Low | 4.74 on 06/21/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 |
| High | 6.44 on 07/11/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | -5.40% since 03/19/24 | +23.88% since 03/19/24 | +14.96% since 03/19/24 | +15.78% since 03/19/24 | +19.99% since 03/19/24 |
| Low | 4.74 on 06/21/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 6.44 on 07/11/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 302,920 | 178,589,936 | 104,514,608 | 122,358,416 | 125,480,912 |
| Shares Outstanding, K | 57,480 | 536,435 | 1,245,853 | 258,053 | 110,186 |
| Annual Sales | 142,520,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | 8,280,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 42,470,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 3,547,100,000 |
| Last Quarter Net Income | 4,430,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 1,432,300,000 |
| 60-Month Beta | 1.07 | 0.61 | 0.18 | 0.40 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.08 on 08/14/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 11/11/24 | 10/29/24 | 11/05/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | 0.006 on 06/13/13 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.59 | 17.89 | 17.67 | 0.00 | 29.85 |